BioXcel Therapeutics (BTAI) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.83
-1.44
-1.06
-0.67

Details

Expected EPS
-0.67494
Actual EPS
-0.87
Surprise EPS
-0.2
Surprise Percent
+28.9%

Description

BioXcel Therapeutics (BTAI) has reported earnings of -0.87 per share for Q2 2024.

0 Comments

Share your thoughts